Ascend Wellness Holdings (AAWH) Change in Accured Expenses (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Change in Accured Expenses came in at $1.9 million in Q1 2026, up 124.36% year-on-year from $863794.3 in Q1 2025, and down 79.15% quarter-over-quarter from $9.3 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 124.36% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $10.5 million, a 202.16% increase from a year earlier, with the FY2025 full-year figure at $595000.0, up 134.88% from the prior year.
- Change in Accured Expenses retreated to $1.9 million in Q1 2026 per AAWH's latest filing, from $9.3 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $14.2 million in Q4 2023 and bottomed at -$9.1 million in Q3 2025.
- The 5-year median for Change in Accured Expenses is $605000.0 (2024), against an average of $1.7 million.
- Biggest YoY gain for Change in Accured Expenses was 1792.09% in 2025; the steepest drop was 1415.04% in 2025.
- Year by year, Change in Accured Expenses stood at -$8.0 million in 2022, then surged by 277.51% to $14.2 million in 2023, then slumped by 76.26% to $3.4 million in 2024, then jumped by 175.6% to $9.3 million in 2025, then plunged by 79.15% to $1.9 million in 2026.
- Per Business Quant, the three latest AAWH Change in Accured Expenses figures stand at $1.9 million (Q1 2026), $9.3 million (Q4 2025), and -$9.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 90.13 Bn | 88.27 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | -144.00 Mn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | -234.00 Mn |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | -12.70 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn | -14.30 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | - |
| 10 | Ascend Wellness Holdings | 77.94 Mn | 17.02 Mn | 44.88 Mn | 1.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.94 Mn |
| Mar 31, 2026 | 1.94 Mn |
| Dec 31, 2025 | 9.30 Mn |
| Dec 31, 2025 | 9.30 Mn |
| Sep 30, 2025 | -9.09 Mn |
| Sep 30, 2025 | -9.09 Mn |
| Jun 30, 2025 | 8.34 Mn |
| Jun 30, 2025 | 8.34 Mn |
| Mar 31, 2025 | -7.96 Mn |
| Mar 31, 2025 | -7.96 Mn |
| Dec 31, 2024 | 3.37 Mn |
| Dec 31, 2024 | 3.37 Mn |
| Sep 30, 2024 | -5.19 Mn |
| Sep 30, 2024 | -5.19 Mn |
| Jun 30, 2024 | -493,000.00 |
| Jun 30, 2024 | -493,000.00 |
| Mar 31, 2024 | 605,000.00 |
| Mar 31, 2024 | 605,000.00 |
| Dec 31, 2023 | 14.21 Mn |
| Dec 31, 2023 | 14.21 Mn |